CAS 67713-23-9
:2,6-dibromobenzaldehyde
Description:
2,6-Dibromobenzaldehyde is an organic compound characterized by the presence of two bromine atoms and an aldehyde functional group attached to a benzene ring. Its molecular structure features a benzene ring substituted at the 2 and 6 positions with bromine atoms, and at the 1 position with a formyl group (-CHO), which is characteristic of aldehydes. This compound typically appears as a pale yellow to brown solid and is known for its aromatic properties. It is soluble in organic solvents such as ethanol and dichloromethane but has limited solubility in water due to its hydrophobic nature. 2,6-Dibromobenzaldehyde is utilized in various chemical syntheses, particularly in the production of pharmaceuticals and agrochemicals, owing to its reactivity and ability to undergo further transformations. Additionally, it may exhibit biological activity, making it of interest in medicinal chemistry. Safety precautions should be taken when handling this compound, as brominated compounds can be hazardous.
Formula:C7H4Br2O
InChI:InChI=1/C7H4Br2O/c8-6-2-1-3-7(9)5(6)4-10/h1-4H
SMILES:c1cc(c(C=O)c(c1)Br)Br
Synonyms:- Benzaldehyde, 2,6-Dibromo-
- 2,6-Dibromobenzenecarbaldehyde
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
2,6-Dibromobenzaldehyde
CAS:Formula:C7H4Br2OPurity:>98.0%(GC)Color and Shape:White to Yellow to Green powder to crystalMolecular weight:263.92Ref: IN-DA006K6T
1g26.00€5g31.00€10g53.00€25g73.00€50g109.00€5kgTo inquire100g197.00€250g322.00€500g581.00€2,6-Dibromobenzaldehyde
CAS:<p>2,6-Dibromobenzaldehyde</p>Formula:C7H4Br2OPurity:95%Color and Shape: beige to brown crystalline solidMolecular weight:263.91g/mol2,6-Dibromobenzaldehyde
CAS:<p>2,6-Dibromobenzaldehyde is an imidazole derivative that has been shown to be a potent inhibitor of tyrosine kinase. It has been shown to inhibit the replication of virus type-1 and is effective in the treatment of pain models. 2,6-Dibromobenzaldehyde also inhibits the activity of enzymes, such as phosphodiesterases and protein kinases. This compound has shown promising results in animal studies for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. The pharmacokinetic properties of 2,6-dibromobenzaldehyde have been studied in rats and dogs with oral administration and found to be linear and rapid with high bioavailability.</p>Formula:C7H4Br2OPurity:Min. 95%Color and Shape:PowderMolecular weight:263.91 g/mol




